 Global Genetically Engineered Vector Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genetically Engineered Vector Vaccine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 202... もっと見る
SummaryThe global Genetically Engineered Vector Vaccine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.A genetically engineered vector vaccine is a type of vaccine that uses a viral vector that has been genetically modified to carry and express genes encoding antigens from a pathogen, such as a virus or bacterium. This approach is part of the broader field of genetic engineering in vaccinology and is designed to stimulate an immune response against the target pathogen. In 2025, the North America Genetically Engineered Vector Vaccine market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period. Major global manufacturers of Genetically Engineered Vector Vaccine include Pfizer, Merck, GSK, Wantai Biotechnology, Watson Bio, Bharat Biotech, Sanofi, Zoties, Elanco, Boehringer Ingelheim, among others. In 2025, the top five players accounted for approximately % of global market revenue. In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %. The global Genetically Engineered Vector Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032. Market Segmentation By Company: Pfizer Merck GSK Wantai Biotechnology Watson Bio Bharat Biotech Sanofi Zoties Elanco Boehringer Ingelheim Indian Immunologicals Zhongmu Industrial Co., Ltd. Qingdao Yibang Bioengineering Co., Ltd. Jinyu Biotechnology Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Tianjin Ruipu Biotechnology Kyoto Biken Laboratories FATRO Ceva Santé Animale Pleco Wuhan Huisheng Biotechnology Jinhe Biotechnology Shenlian Biotechnology Azure Creatures Segment by Type Viral Vector Vaccine Plasmid Vector Vaccine VLPV RNA Vaccine Segment by Application Hospital Clinic Others Macro-Region - North America - Europe - Asia-Pacific - South America - Middle East & Africa Micro-Local Market North America Europe China Japan Chapter Outline Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term Chapter 2: Quantitative analysis of Genetically Engineered Vector Vaccine sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region Chapter 3: Competitive landscape of Genetically Engineered Vector Vaccine manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans) Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment) Chapter 7: Key manufacturer profiles –company overview, Genetically Engineered Vector Vaccine product descriptions and specifications, revenue, gross margins, and recent developments Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies Chapter 11: Key findings, main takeaways, and overall conclusions of the report. Why This Report? Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Genetically Engineered Vector Vaccine value chain, addressing: - Market entry risks/opportunities by region - Product mix optimization based on local practices - Competitor tactics in fragmented vs. consolidated markets Table of Contents1 Market Overview1.1 Genetically Engineered Vector Vaccine Product Scope 1.2 Genetically Engineered Vector Vaccine by Type 1.2.1 Global Genetically Engineered Vector Vaccine Sales by Type (2021, 2025 & 2032) 1.2.2 Viral Vector Vaccine 1.2.3 Plasmid Vector Vaccine 1.2.4 VLPV 1.2.5 RNA Vaccine 1.3 Genetically Engineered Vector Vaccine by Application 1.3.1 Global Genetically Engineered Vector Vaccine Sales Comparison by Application (2021, 2025 & 2032) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Genetically Engineered Vector Vaccine Market Estimates and Forecasts (2021-2032) 1.4.1 Global Genetically Engineered Vector Vaccine Market Size (Value) and Growth Rate (2021-2032) 1.4.2 Global Genetically Engineered Vector Vaccine Market Size (Volume) and Growth Rate (2021-2032) 1.4.3 Global Genetically Engineered Vector Vaccine Price Trends (2021-2032) 1.5 Assumptions and Limitations 2 Market Size and Prospects by Region 2.1 Global Genetically Engineered Vector Vaccine Market Size by Region: 2021 VS 2025 VS 2032 2.2 Global Genetically Engineered Vector Vaccine Historical Market Scenario by Region (2021-2026) 2.2.1 Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2021-2026) 2.2.2 Global Genetically Engineered Vector Vaccine Revenue Market Share by Region (2021-2026) 2.3 Global Genetically Engineered Vector Vaccine Market Estimates and Forecasts by Region (2027-2032) 2.3.1 Global Genetically Engineered Vector Vaccine Sales Estimates and Forecasts by Region (2027-2032) 2.3.2 Global Genetically Engineered Vector Vaccine Revenue Forecast by Region (2027-2032) 2.4 Major Regions and Emerging Market Analysis 2.4.1 North America Genetically Engineered Vector Vaccine Market Size and Prospects (2021-2032) 2.4.2 Europe Genetically Engineered Vector Vaccine Market Size and Prospects (2021-2032) 2.4.3 China Genetically Engineered Vector Vaccine Market Size and Prospects (2021-2032) 2.4.4 Japan Genetically Engineered Vector Vaccine Market Size and Prospects (2021-2032) 3 Global Market Size by Type 3.1 Global Genetically Engineered Vector Vaccine Historical Market Review by Type (2021-2026) 3.1.1 Global Genetically Engineered Vector Vaccine Sales by Type (2021-2026) 3.1.2 Global Genetically Engineered Vector Vaccine Revenue by Type (2021-2026) 3.1.3 Global Genetically Engineered Vector Vaccine Average Price by Type (2021-2026) 3.2 Global Genetically Engineered Vector Vaccine Market Estimates and Forecasts by Type (2027-2032) 3.2.1 Global Genetically Engineered Vector Vaccine Sales Forecast by Type (2027-2032) 3.2.2 Global Genetically Engineered Vector Vaccine Revenue Forecast by Type (2027-2032) 3.2.3 Global Genetically Engineered Vector Vaccine Price Forecast by Type (2027-2032) 3.3 Representative Players for Different Types of Genetically Engineered Vector Vaccine 4 Global Market Size by Application 4.1 Global Genetically Engineered Vector Vaccine Historical Market Review by Application (2021-2026) 4.1.1 Global Genetically Engineered Vector Vaccine Sales by Application (2021-2026) 4.1.2 Global Genetically Engineered Vector Vaccine Revenue by Application (2021-2026) 4.1.3 Global Genetically Engineered Vector Vaccine Average Price by Application (2021-2026) 4.2 Global Genetically Engineered Vector Vaccine Market Estimates and Forecasts by Application (2027-2032) 4.2.1 Global Genetically Engineered Vector Vaccine Sales Forecast by Application (2027-2032) 4.2.2 Global Genetically Engineered Vector Vaccine Revenue Forecast by Application (2027-2032) 4.2.3 Global Genetically Engineered Vector Vaccine Price Forecast by Application (2027-2032) 4.3 New Sources of Growth in Genetically Engineered Vector Vaccine Applications 5 Competition Landscape by Players 5.1 Global Genetically Engineered Vector Vaccine Sales by Player (2021-2026) 5.2 Global Top Genetically Engineered Vector Vaccine Players by Revenue (2021-2026) 5.3 Global Genetically Engineered Vector Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Genetically Engineered Vector Vaccine revenue as of 2025 5.4 Global Genetically Engineered Vector Vaccine Average Price by Company (2021-2026) 5.5 Global Key Manufacturers of Genetically Engineered Vector Vaccine, Manufacturing Sites & Headquarters 5.6 Global Key Manufacturers of Genetically Engineered Vector Vaccine, Product Type & Application 5.7 Global Key Manufacturers of Genetically Engineered Vector Vaccine, Date of Entry into This Industry 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans 6 Regional Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Genetically Engineered Vector Vaccine Sales by Company 6.1.1.1 North America Genetically Engineered Vector Vaccine Sales by Company (2021-2026) 6.1.1.2 North America Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) 6.1.2 North America Genetically Engineered Vector Vaccine Sales Breakdown by Type (2021-2026) 6.1.3 North America Genetically Engineered Vector Vaccine Sales Breakdown by Application (2021-2026) 6.1.4 North America Genetically Engineered Vector Vaccine Major Customers 6.1.5 North America Market Trends and Opportunities 6.2 Europe Market: Players, Segments, Downstream and Major Customers 6.2.1 Europe Genetically Engineered Vector Vaccine Sales by Company 6.2.1.1 Europe Genetically Engineered Vector Vaccine Sales by Company (2021-2026) 6.2.1.2 Europe Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) 6.2.2 Europe Genetically Engineered Vector Vaccine Sales Breakdown by Type (2021-2026) 6.2.3 Europe Genetically Engineered Vector Vaccine Sales Breakdown by Application (2021-2026) 6.2.4 Europe Genetically Engineered Vector Vaccine Major Customers 6.2.5 Europe Market Trends and Opportunities 6.3 China Market: Players, Segments, Downstream and Major Customers 6.3.1 China Genetically Engineered Vector Vaccine Sales by Company 6.3.1.1 China Genetically Engineered Vector Vaccine Sales by Company (2021-2026) 6.3.1.2 China Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) 6.3.2 China Genetically Engineered Vector Vaccine Sales Breakdown by Type (2021-2026) 6.3.3 China Genetically Engineered Vector Vaccine Sales Breakdown by Application (2021-2026) 6.3.4 China Genetically Engineered Vector Vaccine Major Customers 6.3.5 China Market Trends and Opportunities 6.4 Japan Market: Players, Segments, Downstream and Major Customers 6.4.1 Japan Genetically Engineered Vector Vaccine Sales by Company 6.4.1.1 Japan Genetically Engineered Vector Vaccine Sales by Company (2021-2026) 6.4.1.2 Japan Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) 6.4.2 Japan Genetically Engineered Vector Vaccine Sales Breakdown by Type (2021-2026) 6.4.3 Japan Genetically Engineered Vector Vaccine Sales Breakdown by Application (2021-2026) 6.4.4 Japan Genetically Engineered Vector Vaccine Major Customers 6.4.5 Japan Market Trends and Opportunities 7 Company Profiles and Key Figures 7.1 Pfizer 7.1.1 Pfizer Company Information 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.1.4 Pfizer Genetically Engineered Vector Vaccine Products Offered 7.1.5 Pfizer Recent Development 7.2 Merck 7.2.1 Merck Company Information 7.2.2 Merck Business Overview 7.2.3 Merck Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.2.4 Merck Genetically Engineered Vector Vaccine Products Offered 7.2.5 Merck Recent Development 7.3 GSK 7.3.1 GSK Company Information 7.3.2 GSK Business Overview 7.3.3 GSK Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.3.4 GSK Genetically Engineered Vector Vaccine Products Offered 7.3.5 GSK Recent Development 7.4 Wantai Biotechnology 7.4.1 Wantai Biotechnology Company Information 7.4.2 Wantai Biotechnology Business Overview 7.4.3 Wantai Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.4.4 Wantai Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.4.5 Wantai Biotechnology Recent Development 7.5 Watson Bio 7.5.1 Watson Bio Company Information 7.5.2 Watson Bio Business Overview 7.5.3 Watson Bio Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.5.4 Watson Bio Genetically Engineered Vector Vaccine Products Offered 7.5.5 Watson Bio Recent Development 7.6 Bharat Biotech 7.6.1 Bharat Biotech Company Information 7.6.2 Bharat Biotech Business Overview 7.6.3 Bharat Biotech Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.6.4 Bharat Biotech Genetically Engineered Vector Vaccine Products Offered 7.6.5 Bharat Biotech Recent Development 7.7 Sanofi 7.7.1 Sanofi Company Information 7.7.2 Sanofi Business Overview 7.7.3 Sanofi Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.7.4 Sanofi Genetically Engineered Vector Vaccine Products Offered 7.7.5 Sanofi Recent Development 7.8 Zoties 7.8.1 Zoties Company Information 7.8.2 Zoties Business Overview 7.8.3 Zoties Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.8.4 Zoties Genetically Engineered Vector Vaccine Products Offered 7.8.5 Zoties Recent Development 7.9 Elanco 7.9.1 Elanco Company Information 7.9.2 Elanco Business Overview 7.9.3 Elanco Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.9.4 Elanco Genetically Engineered Vector Vaccine Products Offered 7.9.5 Elanco Recent Development 7.10 Boehringer Ingelheim 7.10.1 Boehringer Ingelheim Company Information 7.10.2 Boehringer Ingelheim Business Overview 7.10.3 Boehringer Ingelheim Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.10.4 Boehringer Ingelheim Genetically Engineered Vector Vaccine Products Offered 7.10.5 Boehringer Ingelheim Recent Development 7.11 Indian Immunologicals 7.11.1 Indian Immunologicals Company Information 7.11.2 Indian Immunologicals Business Overview 7.11.3 Indian Immunologicals Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.11.4 Indian Immunologicals Genetically Engineered Vector Vaccine Products Offered 7.11.5 Indian Immunologicals Recent Development 7.12 Zhongmu Industrial Co., Ltd. 7.12.1 Zhongmu Industrial Co., Ltd. Company Information 7.12.2 Zhongmu Industrial Co., Ltd. Business Overview 7.12.3 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.12.4 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Products Offered 7.12.5 Zhongmu Industrial Co., Ltd. Recent Development 7.13 Qingdao Yibang Bioengineering Co., Ltd. 7.13.1 Qingdao Yibang Bioengineering Co., Ltd. Company Information 7.13.2 Qingdao Yibang Bioengineering Co., Ltd. Business Overview 7.13.3 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.13.4 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Products Offered 7.13.5 Qingdao Yibang Bioengineering Co., Ltd. Recent Development 7.14 Jinyu Biotechnology 7.14.1 Jinyu Biotechnology Company Information 7.14.2 Jinyu Biotechnology Business Overview 7.14.3 Jinyu Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.14.4 Jinyu Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.14.5 Jinyu Biotechnology Recent Development 7.15 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences 7.15.1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Company Information 7.15.2 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Business Overview 7.15.3 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.15.4 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Products Offered 7.15.5 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Development 7.16 Tianjin Ruipu Biotechnology 7.16.1 Tianjin Ruipu Biotechnology Company Information 7.16.2 Tianjin Ruipu Biotechnology Business Overview 7.16.3 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.16.4 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.16.5 Tianjin Ruipu Biotechnology Recent Development 7.17 Kyoto Biken Laboratories 7.17.1 Kyoto Biken Laboratories Company Information 7.17.2 Kyoto Biken Laboratories Business Overview 7.17.3 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.17.4 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Products Offered 7.17.5 Kyoto Biken Laboratories Recent Development 7.18 FATRO 7.18.1 FATRO Company Information 7.18.2 FATRO Business Overview 7.18.3 FATRO Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.18.4 FATRO Genetically Engineered Vector Vaccine Products Offered 7.18.5 FATRO Recent Development 7.19 Ceva Santé Animale 7.19.1 Ceva Santé Animale Company Information 7.19.2 Ceva Santé Animale Business Overview 7.19.3 Ceva Santé Animale Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.19.4 Ceva Santé Animale Genetically Engineered Vector Vaccine Products Offered 7.19.5 Ceva Santé Animale Recent Development 7.20 Pleco 7.20.1 Pleco Company Information 7.20.2 Pleco Business Overview 7.20.3 Pleco Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.20.4 Pleco Genetically Engineered Vector Vaccine Products Offered 7.20.5 Pleco Recent Development 7.21 Wuhan Huisheng Biotechnology 7.21.1 Wuhan Huisheng Biotechnology Company Information 7.21.2 Wuhan Huisheng Biotechnology Business Overview 7.21.3 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.21.4 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.21.5 Wuhan Huisheng Biotechnology Recent Development 7.22 Jinhe Biotechnology 7.22.1 Jinhe Biotechnology Company Information 7.22.2 Jinhe Biotechnology Business Overview 7.22.3 Jinhe Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.22.4 Jinhe Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.22.5 Jinhe Biotechnology Recent Development 7.23 Shenlian Biotechnology 7.23.1 Shenlian Biotechnology Company Information 7.23.2 Shenlian Biotechnology Business Overview 7.23.3 Shenlian Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.23.4 Shenlian Biotechnology Genetically Engineered Vector Vaccine Products Offered 7.23.5 Shenlian Biotechnology Recent Development 7.24 Azure Creatures 7.24.1 Azure Creatures Company Information 7.24.2 Azure Creatures Business Overview 7.24.3 Azure Creatures Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2021-2026) 7.24.4 Azure Creatures Genetically Engineered Vector Vaccine Products Offered 7.24.5 Azure Creatures Recent Development 8 Genetically Engineered Vector Vaccine Manufacturing Cost Analysis 8.1 Genetically Engineered Vector Vaccine Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Suppliers of Raw Materials 8.2 Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Genetically Engineered Vector Vaccine 8.4 Genetically Engineered Vector Vaccine Industrial Chain Analysis 9 Marketing Channels, Distributors and Customers 9.1 Marketing Channels 9.2 Genetically Engineered Vector Vaccine Distributors List 9.3 Genetically Engineered Vector Vaccine Customers 10 Genetically Engineered Vector Vaccine Market Dynamics 10.1 Genetically Engineered Vector Vaccine Industry Trends 10.2 Genetically Engineered Vector Vaccine Market Drivers 10.3 Genetically Engineered Vector Vaccine Market Challenges 10.4 Genetically Engineered Vector Vaccine Market Restraints 11 Research Findings and Conclusion 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.1.1 Research Programs/Design 12.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 12.1.2 Data Source 12.1.2.1 Secondary Sources 12.1.2.2 Primary Sources 12.2 Author Details 12.3 Disclaimer List of Tables/GraphsList of TablesTable 1. Global Genetically Engineered Vector Vaccine Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032) Table 2. Global Genetically Engineered Vector Vaccine Sales (US$ Million) Comparison by Application (2021, 2025 & 2032) Table 3. Global Market Genetically Engineered Vector Vaccine Market Size (US$ Million) by Region:2021 VS 2025 VS 2032 Table 4. Global Genetically Engineered Vector Vaccine Sales (K Units) by Region (2021-2026) Table 5. Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2021-2026) Table 6. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) Market Share by Region (2021-2026) Table 7. Global Genetically Engineered Vector Vaccine Revenue Share by Region (2021-2026) Table 8. Global Genetically Engineered Vector Vaccine Sales (K Units) Forecast by Region (2027-2032) Table 9. Global Genetically Engineered Vector Vaccine Sales Market Share Forecast by Region (2027-2032) Table 10. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) Forecast by Region (2027-2032) Table 11. Global Genetically Engineered Vector Vaccine Revenue Share Forecast by Region (2027-2032) Table 12. Global Genetically Engineered Vector Vaccine Sales by Type (K Units) & (2021-2026) Table 13. Global Genetically Engineered Vector Vaccine Sales Share by Type (2021-2026) Table 14. Global Genetically Engineered Vector Vaccine Revenue by Type (US$ Million) & (2021-2026) Table 15. Global Genetically Engineered Vector Vaccine Average Price by Type (US$/Unit) & (2021-2026) Table 16. Global Genetically Engineered Vector Vaccine Sales by Type (K Units) & (2027-2032) Table 17. Global Genetically Engineered Vector Vaccine Revenue by Type (US$ Million) & (2027-2032) Table 18. Global Genetically Engineered Vector Vaccine Average Price by Type (US$/Unit) & (2027-2032) Table 19. Representative Players of Each Type Table 20. Global Genetically Engineered Vector Vaccine Sales by Application (K Units) & (2021-2026) Table 21. Global Genetically Engineered Vector Vaccine Sales Share by Application (2021-2026) Table 22. Global Genetically Engineered Vector Vaccine Revenue by Application (US$ Million) & (2021-2026) Table 23. Global Genetically Engineered Vector Vaccine Average Price by Application (US$/Unit) & (2021-2026) Table 24. Global Genetically Engineered Vector Vaccine Sales by Application (K Units) & (2027-2032) Table 25. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (US$ Million) & (2027-2032) Table 26. Global Genetically Engineered Vector Vaccine Average Price by Application (US$/Unit) & (2027-2032) Table 27. New Sources of Growth in Genetically Engineered Vector Vaccine Applications Table 28. Global Genetically Engineered Vector Vaccine Sales by Company (K Units) & (2021-2026) Table 29. Global Genetically Engineered Vector Vaccine Sales Share by Company (2021-2026) Table 30. Global Genetically Engineered Vector Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Genetically Engineered Vector Vaccine Revenue Share by Company (2021-2026) Table 32. Global Genetically Engineered Vector Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Engineered Vector Vaccine as of 2025) Table 33. Global Market Genetically Engineered Vector Vaccine Average Price by Company (US$/Unit) & (2021-2026) Table 34. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Manufacturing Sites & Headquarters Table 35. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Product Type & Application Table 36. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Date of Entry into This Industry Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans Table 38. North America Genetically Engineered Vector Vaccine Sales by Company (2021-2026) & (K Units) Table 39. North America Genetically Engineered Vector Vaccine Sales Market Share by Company (2021-2026) Table 40. North America Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) & (US$ Million) Table 41. North America Genetically Engineered Vector Vaccine Revenue Market Share by Company (2021-2026) Table 42. North America Genetically Engineered Vector Vaccine Sales by Type (2021-2026) & (K Units) Table 43. North America Genetically Engineered Vector Vaccine Sales Market Share by Type (2021-2026) Table 44. North America Genetically Engineered Vector Vaccine Sales by Application (2021-2026) & (K Units) Table 45. North America Genetically Engineered Vector Vaccine Sales Market Share by Application (2021-2026) Table 46. Europe Genetically Engineered Vector Vaccine Sales by Company (2021-2026) & (K Units) Table 47. Europe Genetically Engineered Vector Vaccine Sales Market Share by Company (2021-2026) Table 48. Europe Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) & (US$ Million) Table 49. Europe Genetically Engineered Vector Vaccine Revenue Market Share by Company (2021-2026) Table 50. Europe Genetically Engineered Vector Vaccine Sales by Type (2021-2026) & (K Units) Table 51. Europe Genetically Engineered Vector Vaccine Sales Market Share by Type (2021-2026) Table 52. Europe Genetically Engineered Vector Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Europe Genetically Engineered Vector Vaccine Sales Market Share by Application (2021-2026) Table 54. China Genetically Engineered Vector Vaccine Sales by Company (2021-2026) & (K Units) Table 55. China Genetically Engineered Vector Vaccine Sales Market Share by Company (2021-2026) Table 56. China Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) & (US$ Million) Table 57. China Genetically Engineered Vector Vaccine Revenue Market Share by Company (2021-2026) Table 58. China Genetically Engineered Vector Vaccine Sales by Type (2021-2026) & (K Units) Table 59. China Genetically Engineered Vector Vaccine Sales Market Share by Type (2021-2026) Table 60. China Genetically Engineered Vector Vaccine Sales by Application (2021-2026) & (K Units) Table 61. China Genetically Engineered Vector Vaccine Sales Market Share by Application (2021-2026) Table 62. Japan Genetically Engineered Vector Vaccine Sales by Company (2021-2026) & (K Units) Table 63. Japan Genetically Engineered Vector Vaccine Sales Market Share by Company (2021-2026) Table 64. Japan Genetically Engineered Vector Vaccine Revenue by Company (2021-2026) & (US$ Million) Table 65. Japan Genetically Engineered Vector Vaccine Revenue Market Share by Company (2021-2026) Table 66. Japan Genetically Engineered Vector Vaccine Sales by Type (2021-2026) & (K Units) Table 67. Japan Genetically Engineered Vector Vaccine Sales Market Share by Type (2021-2026) Table 68. Japan Genetically Engineered Vector Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Japan Genetically Engineered Vector Vaccine Sales Market Share by Application (2021-2026) Table 70. Pfizer Company Information Table 71. Pfizer Description and Business Overview Table 72. Pfizer Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Pfizer Genetically Engineered Vector Vaccine Product Table 74. Pfizer Recent Development Table 75. Merck Company Information Table 76. Merck Description and Business Overview Table 77. Merck Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Genetically Engineered Vector Vaccine Product Table 79. Merck Recent Development Table 80. GSK Company Information Table 81. GSK Description and Business Overview Table 82. GSK Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GSK Genetically Engineered Vector Vaccine Product Table 84. GSK Recent Development Table 85. Wantai Biotechnology Company Information Table 86. Wantai Biotechnology Description and Business Overview Table 87. Wantai Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Wantai Biotechnology Genetically Engineered Vector Vaccine Product Table 89. Wantai Biotechnology Recent Development Table 90. Watson Bio Company Information Table 91. Watson Bio Description and Business Overview Table 92. Watson Bio Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Watson Bio Genetically Engineered Vector Vaccine Product Table 94. Watson Bio Recent Development Table 95. Bharat Biotech Company Information Table 96. Bharat Biotech Description and Business Overview Table 97. Bharat Biotech Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Bharat Biotech Genetically Engineered Vector Vaccine Product Table 99. Bharat Biotech Recent Development Table 100. Sanofi Company Information Table 101. Sanofi Description and Business Overview Table 102. Sanofi Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sanofi Genetically Engineered Vector Vaccine Product Table 104. Sanofi Recent Development Table 105. Zoties Company Information Table 106. Zoties Description and Business Overview Table 107. Zoties Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Zoties Genetically Engineered Vector Vaccine Product Table 109. Zoties Recent Development Table 110. Elanco Company Information Table 111. Elanco Description and Business Overview Table 112. Elanco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Elanco Genetically Engineered Vector Vaccine Product Table 114. Elanco Recent Development Table 115. Boehringer Ingelheim Company Information Table 116. Boehringer Ingelheim Description and Business Overview Table 117. Boehringer Ingelheim Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Boehringer Ingelheim Genetically Engineered Vector Vaccine Product Table 119. Boehringer Ingelheim Recent Development Table 120. Indian Immunologicals Company Information Table 121. Indian Immunologicals Description and Business Overview Table 122. Indian Immunologicals Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Indian Immunologicals Genetically Engineered Vector Vaccine Product Table 124. Indian Immunologicals Recent Development Table 125. Zhongmu Industrial Co., Ltd. Company Information Table 126. Zhongmu Industrial Co., Ltd. Description and Business Overview Table 127. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product Table 129. Zhongmu Industrial Co., Ltd. Recent Development Table 130. Qingdao Yibang Bioengineering Co., Ltd. Company Information Table 131. Qingdao Yibang Bioengineering Co., Ltd. Description and Business Overview Table 132. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product Table 134. Qingdao Yibang Bioengineering Co., Ltd. Recent Development Table 135. Jinyu Biotechnology Company Information Table 136. Jinyu Biotechnology Description and Business Overview Table 137. Jinyu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Jinyu Biotechnology Genetically Engineered Vector Vaccine Product Table 139. Jinyu Biotechnology Recent Development Table 140. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Company Information Table 141. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Description and Business Overview Table 142. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product Table 144. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Development Table 145. Tianjin Ruipu Biotechnology Company Information Table 146. Tianjin Ruipu Biotechnology Description and Business Overview Table 147. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product Table 149. Tianjin Ruipu Biotechnology Recent Development Table 150. Kyoto Biken Laboratories Company Information Table 151. Kyoto Biken Laboratories Description and Business Overview Table 152. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product Table 154. Kyoto Biken Laboratories Recent Development Table 155. FATRO Company Information Table 156. FATRO Description and Business Overview Table 157. FATRO Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. FATRO Genetically Engineered Vector Vaccine Product Table 159. FATRO Recent Development Table 160. Ceva Santé Animale Company Information Table 161. Ceva Santé Animale Description and Business Overview Table 162. Ceva Santé Animale Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Ceva Santé Animale Genetically Engineered Vector Vaccine Product Table 164. Ceva Santé Animale Recent Development Table 165. Pleco Company Information Table 166. Pleco Description and Business Overview Table 167. Pleco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Pleco Genetically Engineered Vector Vaccine Product Table 169. Pleco Recent Development Table 170. Wuhan Huisheng Biotechnology Company Information Table 171. Wuhan Huisheng Biotechnology Description and Business Overview Table 172. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product Table 174. Wuhan Huisheng Biotechnology Recent Development Table 175. Jinhe Biotechnology Company Information Table 176. Jinhe Biotechnology Description and Business Overview Table 177. Jinhe Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Jinhe Biotechnology Genetically Engineered Vector Vaccine Product Table 179. Jinhe Biotechnology Recent Development Table 180. Shenlian Biotechnology Company Information Table 181. Shenlian Biotechnology Description and Business Overview Table 182. Shenlian Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. Shenlian Biotechnology Genetically Engineered Vector Vaccine Product Table 184. Shenlian Biotechnology Recent Development Table 185. Azure Creatures Company Information Table 186. Azure Creatures Description and Business Overview Table 187. Azure Creatures Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. Azure Creatures Genetically Engineered Vector Vaccine Product Table 189. Azure Creatures Recent Development Table 190. Production Base and Market Concentration Rate of Raw Material Table 191. Key Suppliers of Raw Materials Table 192. Genetically Engineered Vector Vaccine Distributors List Table 193. Genetically Engineered Vector Vaccine Customers List Table 194. Genetically Engineered Vector Vaccine Market Trends Table 195. Genetically Engineered Vector Vaccine Market Drivers Table 196. Genetically Engineered Vector Vaccine Market Challenges Table 197. Genetically Engineered Vector Vaccine Market Restraints Table 198. Research Programs/Design for This Report Table 199. Key Data Information from Secondary Sources Table 200. Key Data Information from Primary Sources List of Figures Figure 1. Genetically Engineered Vector Vaccine Product Picture Figure 2. Global Genetically Engineered Vector Vaccine Sales (US$ Million) by Type (2021, 2025 & 2032) Figure 3. Global Genetically Engineered Vector Vaccine Sales Market Share by Type in 2025 & 2032 Figure 4. Viral Vector Vaccine Product Picture Figure 5. Plasmid Vector Vaccine Product Picture Figure 6. VLPV Product Picture Figure 7. RNA Vaccine Product Picture Figure 8. Global Genetically Engineered Vector Vaccine Sales (US$ Million) by Application (2021, 2025 & 2032) Figure 9. Global Genetically Engineered Vector Vaccine Sales Market Share by Application in 2025 & 2032 Figure 10. Hospital Examples Figure 11. Clinic Examples Figure 12. Others Examples Figure 13. Global Genetically Engineered Vector Vaccine Sales, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Genetically Engineered Vector Vaccine Sales Growth Rate (2021-2032) & (US$ Million) Figure 15. Global Genetically Engineered Vector Vaccine Sales (K Units) Growth Rate (2021-2032) Figure 16. Global Genetically Engineered Vector Vaccine Price Trends Growth Rate (2021-2032) & (US$/Unit) Figure 17. Genetically Engineered Vector Vaccine Report Years Considered Figure 18. Global Market Genetically Engineered Vector Vaccine Market Size (US$ Million) by Region:2021 VS 2025 VS 2032 Figure 19. Global Genetically Engineered Vector Vaccine Revenue Market Share by Region: 2021 VS 2025 Figure 20. North America Genetically Engineered Vector Vaccine Revenue (US$ Million) Growth Rate (2021-2032) Figure 21. North America Genetically Engineered Vector Vaccine Sales (K Units) Growth Rate (2021-2032) Figure 22. Europe Genetically Engineered Vector Vaccine Revenue (US$ Million) Growth Rate (2021-2032) Figure 23. Europe Genetically Engineered Vector Vaccine Sales (K Units) Growth Rate (2021-2032) Figure 24. China Genetically Engineered Vector Vaccine Revenue (US$ Million) Growth Rate (2021-2032) Figure 25. China Genetically Engineered Vector Vaccine Sales (K Units) Growth Rate (2021-2032) Figure 26. Japan Genetically Engineered Vector Vaccine Revenue (US$ Million) Growth Rate (2021-2032) Figure 27. Japan Genetically Engineered Vector Vaccine Sales (K Units) Growth Rate (2021-2032) Figure 28. Global Genetically Engineered Vector Vaccine Revenue Share by Type (2021-2026) Figure 29. Global Genetically Engineered Vector Vaccine Sales Share by Type (2027-2032) Figure 30. Global Genetically Engineered Vector Vaccine Revenue Share by Type (2027-2032) Figure 31. Global Genetically Engineered Vector Vaccine Revenue Share by Application (2021-2026) Figure 32. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application in 2021 & 2025 Figure 33. Global Genetically Engineered Vector Vaccine Sales Share by Application (2027-2032) Figure 34. Global Genetically Engineered Vector Vaccine Revenue Share by Application (2027-2032) Figure 35. Global Genetically Engineered Vector Vaccine Sales Share by Company (2025) Figure 36. Global Genetically Engineered Vector Vaccine Revenue Share by Company (2025) Figure 37. Global 5 Largest Genetically Engineered Vector Vaccine Players Market Share by Revenue in Genetically Engineered Vector Vaccine: 2021 & 2025 Figure 38. Genetically Engineered Vector Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 39. Manufacturing Cost Structure of Genetically Engineered Vector Vaccine Figure 40. Manufacturing Process Analysis of Genetically Engineered Vector Vaccine Figure 41. Genetically Engineered Vector Vaccine Industrial Chain Figure 42. Channels of Distribution (Direct Vs Distribution) Figure 43. Distributors Profiles Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（vector）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
